Efficient Treatment of Sporothrix globosa Infection Using the Antibody Elicited by Recombinant Phage Nanofibers
Antifungal therapy is used to treat sporotrichosis. However, there are several limitations in this therapy, such as development of drug resistance and potential health risks including liver injury. The purpose of our study was to evaluate the antifungal efficacy of antibody against the hybrid phage...
Saved in:
Main Authors: | Feng Chen (Author), Rihua Jiang (Author), Shuai Dong (Author), Bailing Yan (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2019-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Recombinant phage displaying ToAP2D peptide with antifungal activity against Sporothrix globosa
by: Tianyi Yan, et al.
Published: (2022) -
Fixed Cutaneous Sporotrichosis Due to Sporothrix globosa
by: Liu F, et al.
Published: (2021) -
Fast diagnosis of sporotrichosis caused by Sporothrix globosa, Sporothrix schenckii, and Sporothrix brasiliensis based on multiplex real-time PCR.
by: Mingrui Zhang, et al.
Published: (2019) -
Evaluation of virulence and drug resistance of Sporothrix globosa itraconazole-resistant strains in Galleria mellonella
by: Jing ZHANG, et al.
Published: (2020) -
An unhealing wound and subcutaneous nodules due to Sporothrix globosa after a cat bite.
by: Yanbin Liu, et al.
Published: (2020)